Neith Corporation (TPEX:6236)
Taiwan · Delayed Price · Currency is TWD 23.40
-2.60 (-10.00%)
At close: Feb 11, 2026
Neith Market Cap
Neith has a market cap or net worth of 974.7 million as of February 11, 2026. Its market cap has decreased by -17.89% in one year.
Market Cap
974.70M
Enterprise Value
843.46M
Revenue
39.35M
Ranking
n/a
PE Ratio
265.95
Stock Price
23.40
Market Cap Chart
Since November 3, 2004, Neith's market cap has increased from 483.77M to 974.70M, an increase of 101.48%. That is a compound annual growth rate of 3.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 974.70M | 8.58% |
| Dec 30, 2025 | 897.64M | -27.93% |
| Dec 27, 2024 | 1.25B | -13.21% |
| Dec 29, 2023 | 1.43B | 166.67% |
| Dec 30, 2022 | 538.12M | 47.83% |
| Dec 30, 2021 | 364.02M | 7.98% |
| Dec 28, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Great Novel Therapeutics Biotech & Medicals | 1.46B |
| Enimmune | 1.43B |
| Meribank Biotech | 1.30B |
| GeneReach Biotechnology | 1.20B |
| Lukas Biomedical | 1.19B |
| Holy Stone Healthcare | 1.13B |
| Level Biotechnology | 1.07B |
| TCI GENE | 1.01B |